首页> 外文OA文献 >PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. ORAL IBANDRONATE OR IV GENERIC PAMIDRONATE IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK NHS PERSPECTIVE

【2h】

PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. ORAL IBANDRONATE OR IV GENERIC PAMIDRONATE IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK NHS PERSPECTIVE

机译：静脉（IV）佐力膦酸VS的PCN5预算影响分析。口服IBANDRONATE或IV通用PAMIDRONATE在预防患有骨转移的乳腺癌患者的骨并发症中的作用：英国NHS的观点

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Botteman M; Aapro M; Stephens J; Hay JW; Brandman J;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom. [J] . De Cock E, Hutton J, Canney P, Clinical therapeutics . 2005,第8期

机译：在英国，口服伊班膦酸与IV唑来膦酸或IV帕米膦酸在接受口服激素治疗乳腺癌的患者中的骨转移的成本效益。
2. Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy. [J] . De Cock E, Hutton J, Canney P, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2005,第12期

机译：与静脉注射唑来膦酸或静脉注射唑来膦酸相比，口服伊班膦酸酯的成本效益高。接受i.v.治疗的患有转移性骨疾病的乳腺癌患者的通用帕米膦酸化学疗法。
3. Phase III trial of oral ibandronate and intravenous zoledronic acid in breast cancer patients with bone metastases: comparative bone turnover marker and safety data [J] . J.-J.Body, Lichinitser, S.Tjulandin, European Journal of Cancer Supplements . 2006,第2期

机译：患有骨转移的乳腺癌患者口服伊班膦酸和唑来膦酸口服液的III期试验：比较骨转换指标和安全性数据
4. Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer [O] . J.F. Hilton, M. Clemons, G. Pond, 2018

机译：乳腺癌患者高风险骨转移对持续帕米膦酸或转换为唑来膦酸对骨吸收标志物的影响
5. PCN4 ECONOMIC EVALUATION OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. OTHER IV BISPHOSPHONATES IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK BUDGET IMPACT ANALYSIS [O] . Botteman M, Aapro M, Hay JW, 2005

机译：PCN4静脉内（IV）佐敦酸的经济评估VS.其他IV双歧杆菌在预防患有骨转移的乳腺癌患者中的骨并发症：英国预算影响分析

PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. ORAL IBANDRONATE OR IV GENERIC PAMIDRONATE IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK NHS PERSPECTIVE

著录项

相似文献

相关主题

期刊订阅